Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes.
about
Culture-independent detection and characterisation of Mycobacterium tuberculosis and M. africanum in sputum samples using shotgun metagenomics on a benchtop sequencerThe implications of whole-genome sequencing in the control of tuberculosisReply to "molecular diagnosis of rifampin-monoresistant tuberculosis in Indian patients: problems with a discordance analysis"Advanced immune suppression is associated with increased prevalence of mixed-strain Mycobacterium tuberculosis infections among persons at high risk for drug-resistant tuberculosis in BotswanaHigh Genotypic Discordance of Concurrent Mycobacterium tuberculosis Isolates from Sputum and Blood of HIV-Infected Individuals.Mixed Infections and Rifampin Heteroresistance among Mycobacterium tuberculosis Clinical Isolates.Mycobacterium tuberculosis causing tuberculous lymphadenitis in Maputo, Mozambique.Genotypic, Phenotypic and Clinical Validation of GeneXpert in Extra-Pulmonary and Pulmonary Tuberculosis in India.Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia.False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load.Within-Host Heterogeneity of Mycobacterium tuberculosis Infection Is Associated With Poor Early Treatment Response: A Prospective Cohort StudyRapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study.Evaluation of the impact of polyclonal infection and heteroresistance on treatment of tuberculosis patients.Evaluation of the Cepheid Xpert MTB/RIF assay.Multiplex detection of extensively drug resistant tuberculosis using binary deoxyribozyme sensors.Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran.The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing.Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru.Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis.An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF.Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance.Evolution of Phenotypic and Molecular Drug Susceptibility Testing.Emergence of mixed infection of Beijing/Non-Beijing strains among multi-drug resistant Mycobacterium tuberculosis in Pakistan.Next-Generation Sequencing for Characterizing Drug Resistant Mycobacterium tuberculosis Genes from Clinical Isolates in the Ukraine.Mutations of rpob Gene Associated with Rifampin Resistance among Mycobacterium Tuberculosis Isolated in Tuberculosis Regional Reference Laboratory in Northeast of Iran during 2015–2016.Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing
P2860
Q21128711-16220776-90AF-45BD-B7CB-1AA7EFBF8BB4Q26749040-BF93D75B-C15E-4614-8F3C-B4FF8C19EFD0Q35035902-FBAE86F5-1D06-48B5-A462-9080CA231665Q35152791-A5256173-1C7A-4FBA-99C3-DD19C1FB9DA4Q35691978-CC53E38E-953D-4B76-9FD4-533243AC4102Q35757559-4BB76BDE-A29E-4E8C-AB92-C194AADC165EQ35847691-E97D3089-C0D1-4745-8367-629C0018FCE1Q35928273-29E398A8-BA62-431A-B457-8A159E24017DQ36617071-BE625342-7A0C-4DDC-9ECC-FDE438445EB2Q36827305-523A26CB-ABF1-4D0F-B1F0-2292EADC32B7Q36871940-7D648F71-84D9-4341-95B2-8BF7EAB6787DQ37132034-3B1B5F00-36A5-4B0F-A712-E310E9497BCBQ37605137-A6BC910C-A9BD-46EA-9D50-8EC770C2ACB0Q38265418-8347B131-3009-496B-A421-AA32A27865DEQ40298558-F36B74AF-3535-488E-B568-07CB59B6F4F4Q41288770-604853F6-584F-4433-A8AC-11AA8103E941Q41546193-152D3D04-A195-4E79-A10B-6FCF516073B5Q42650259-F4E95F45-E5D2-4FDA-B204-463592A49EA5Q43200303-E459D4DF-87C4-4130-9089-64E83C422166Q43905628-C155C184-9645-482D-AFD5-9194B785A7F0Q46589487-97C5A043-B5BA-411B-8F48-7D9233CFA4F5Q47632774-D129C862-324E-4D28-B892-ACDCCE63B058Q52427251-94B56E61-3CDB-4C93-96EB-1037C75C9B96Q52644112-E97949B2-6669-4AB8-AEB6-A0496BDB7DA3Q55440809-82FE4966-037B-4250-81C8-3629A9650E2DQ56395612-D707667C-0C8F-46B7-85CC-FD2B09561DE7
P2860
Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mixed Mycobacterium tuberculos ...... d with poor clinical outcomes.
@ast
Mixed Mycobacterium tuberculos ...... d with poor clinical outcomes.
@en
type
label
Mixed Mycobacterium tuberculos ...... d with poor clinical outcomes.
@ast
Mixed Mycobacterium tuberculos ...... d with poor clinical outcomes.
@en
prefLabel
Mixed Mycobacterium tuberculos ...... d with poor clinical outcomes.
@ast
Mixed Mycobacterium tuberculos ...... d with poor clinical outcomes.
@en
P2093
P2860
P50
P356
P1476
Mixed Mycobacterium tuberculos ...... d with poor clinical outcomes.
@en
P2093
Jeffrey D Klausner
Kefentse A Tumedi
Keletso Moeti
Nicola M Zetola
Ronald Ncube
Sanghyuk S Shin
P2860
P304
P356
10.1128/JCM.02489-13
P407
P577
2014-04-30T00:00:00Z